970 



INDEX 



Serum treatment, methods of inocula- 

 tion, 739 

 normal, 829 



in hemorrhage, 829 

 in nephritis, 834 

 in skin diseases, 834 

 in toxicoses of pregnancy, 833 

 in vomiting of pregnancy, 833 

 of acute anterior poliomyelitis, 826 

 of anthrax, 820 

 of bubonic plague, 822 

 of cerebrospinal meningitis, 788 

 of cholera, 823 



of diphtheria, 754. See also Diph- 

 theria antitoxin. 

 of dysentery, 782 



results, 783 



of gonococcal infections, 818 

 of hay-fever, 786 

 of hog cholera, 784 

 of infantile paralysis, 826 

 of infectious diseases with specific 

 serum of convalescents and with 

 normal serum, 825 

 of influenzal meningitis, 802 

 of internal anthrax, 821 

 of meningococcus meningitis, 788 

 cases of posterior basal menin- 

 gitis, 798 



with dry canal, 798 

 with thick elastic exudate, 798 

 chronic cases, 799 

 results, 799 

 serum sickness in, 799 

 subacute cases, 799 

 of plague, 822 

 of pneumococcus infections, 807 



meningitis, 804, 805 

 of pneumonia, 807, 828 



results, 812 

 of scarlet fever, 825 

 of snake-bites, 786 

 of staphylococcus infections, 819 

 of streptococcus infections, 813 

 of tetanus, 772. See also Tetanus 



antitoxin. 



of tuberculosis, 824 

 of typhoid fever, 821 

 purposes, 734 

 status lymphaticus in, 739 

 subcutaneous inoculation, technic, 



740 

 subdural inoculation, technic, 746. 



See also Subdural inoculation. 

 Sheep, anaphylaxis in, 577 

 intravenous inoculation, 62 

 obtaining large amount of blood from, 



small amount of blood from, 42, 49 

 Side-chain theory of immunity, 148 



and phagocytic theory, compati- 

 bility, 157 



Simon and Lamar's modification of 



Wright's method for opsonic index, 203 



Skin as portal of entrance for bacteria, 87 



Skin, bacteria on, 85, 87 



diseases, autoserum treatment, 835 

 normal serum treatment, 834 

 salvarsan in, 881 

 vaccine therapy, 704 

 reactions, allergic, 620 



as indices of immunity, 622 



of infection and hypersuscepti- 



bility, 621 

 effect of drugs, 644 

 etiology, 620 



tuberculosis of, tuberculin test in diag- 

 nosis of, 631 

 treatment, 731 

 Smallpox, antistreptococcus serum in, 



817 



revaccination, 679 

 salvarsan in, 881 

 vaccination, 668. See also Vaccination, 



smallpox. 



vaccinia and, relationship, 670 

 Smith's phenomenon of anaphylaxis, 571 

 Snake venoms, 121, 251 

 nature of, 121 

 properties of, 121 

 Snake-bites, serum treatment, 786 

 Sodium citrate, 27 



salvarsan, 856 

 Sol, definition, 544 

 Solutions, 27 



colloidal, 544 



Southard and Gay's theory of anaphy- 

 laxis, 592 

 Species immunity, 168 



susceptibility, 101 

 Spermatotoxin, 538 

 Spinal cord, syphilis of, salvarsanized 



autoserum in, 836 

 after-treatment, 839 

 repeating dose, 840 

 serobiologic findings in cere- 

 brospinal fluid, 840 

 technic, 838 



puncture, 37. See also Lumbar punc- 

 ture. 



Splitting of complement, 353 

 Spontaneous phagocytosis, 190 

 Sporadic infection, 82 

 Sporotrichosis, allergic reactions in, 653 

 Stain, blood, biologic test for, 326 



technic, 331 

 experimental work, 921 

 identification of, complement-fixa- 

 tion test for, 527 

 test for, experimental work, 937 

 seminal, test for, 327 

 Staining acid-fast bacilli, 200 



bacteria, 200 



Stalagmometer, Traube's, 563 

 Standardization of antimeningococcus 



serum, 792 



of antipneumococcus serum, 811 

 1 of antistreptococcus serum, 816 

 of bacterial antigens in complement 

 fixation, 500 



